Remove spotlight visual-investigations
article thumbnail

Zolbetuximab Is a Promising Therapy for HER2-Negative Gastric Cancer

XTalks

Consequently, new therapies are continuously investigated to increase and prolong survival rates. This investigational first-in-class Claudin 18.2 Phase III Clinical Trials Underpinning the Applications The applications are grounded on two Phase III clinical trials, SPOTLIGHT and GLOW. percent compared to CAPOX alone.

article thumbnail

How Can a Central Lab Deliver Essential Lab Data and Optimize Study Timelines?

XTalks

It includes a proprietary web-based enterprise and information management system for the central lab to provide a fast and accurate study startup, as well as data visualizations and interactive reporting tools to turn data into actionable intelligence. It has kind of been a black box until you develop tools that allow for that.”